Skip to main content
Because solifenacin is a substrate of CYP3A4, inducers or inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, and erythromycin) may alter solifenacin pharmacokinetics.

Drug Criteria & Outcomes: Solifenacin succinate (Vesicare) Formulary Evaluation

April 1, 2005

Because solifenacin is a substrate of CYP3A4, inducers or inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, and erythromycin) may alter solifenacin pharmacokinetics.